Practically Speaking: Perioperative management of NSCLC - Make it Stop Spinning!

To be added to the distribution list, please email: DDeCastro@southlakeregional.org

In this episode, Dr. Paul Wheatley-Price will help navigate the dizzying data as it pertains to peri-operative therapy for NSCLC with a special focus on Checkmate 816, Keynote 671 and AEGEAN.

Key Opinion Leader: 

Paul Wheatley-Price BSc, MBChB, FRCP (UK), MD
Associate Professor of Medicine, University of Ottawa
Division of Medical Oncology

Host:
Shaqil Kassam MD. MSc. FRCPC
skassam@southlakeregional.org
Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Outline:
0:00 – Introduction
3:00 – Speaker Biography
4:00 – Is there a SOC in Perioperative Management for NSCLC
7:45 – Is there a difference between Nivo, Pembro or Durva?
12:30 - Neo-adjuvant, Adjuvant or both?  Can we use PCR to choose
20:45 – Who goes straight to surgery. 
26:00 – Chemo backbone with Immunotherapy
27:40 – Immunotherapy and other Actionable Mutations
30:10 – What to do on progression
35:00 – How late is too late to start Adjuvant therapy. 

Previous episodes: https://www.blogtalkradio.com/medoncnow